Thyrogen Alert: New Global shortage of Thyrogen® through mid-Nov. (ATA)
(Oct. 28, 2010) Genzyme Corporation (Cambridge, MA), currently under a consent decree with the U.S. Food and Drug Administration (FDA) regarding manufacturing issues of several products including Thyrogen®, is experiencing a new delay in its product release.
This delay will affect the supply of Thyrogen® both in the US and globally such that it is unlikely that Thyrogen® will be available for use starting immediately. Healthcare providers and patients should therefore plan accordingly. The duration of the shortage is uncertain; however, the current best estimate is that it will last through mid- November. It may be advisable to not schedule use of Thyrogen® until product is confirmed to be available through your normal method of obtaining Thyrogen®. Additional information will be provided as it becomes available.
American Thyroid Association
(703) 998-8890
thyroid@thyroid.org
www.thyroid.org
(Oct. 28, 2010) Genzyme Corporation (Cambridge, MA), currently under a consent decree with the U.S. Food and Drug Administration (FDA) regarding manufacturing issues of several products including Thyrogen®, is experiencing a new delay in its product release.
This delay will affect the supply of Thyrogen® both in the US and globally such that it is unlikely that Thyrogen® will be available for use starting immediately. Healthcare providers and patients should therefore plan accordingly. The duration of the shortage is uncertain; however, the current best estimate is that it will last through mid- November. It may be advisable to not schedule use of Thyrogen® until product is confirmed to be available through your normal method of obtaining Thyrogen®. Additional information will be provided as it becomes available.
American Thyroid Association
(703) 998-8890
thyroid@thyroid.org
www.thyroid.org
Posts
